MCID: LYM006
MIFTS: 43

Lymphoepithelioma-Like Carcinoma malady

Categories: Cancer diseases, Immune diseases

Aliases & Classifications for Lymphoepithelioma-Like Carcinoma

Aliases & Descriptions for Lymphoepithelioma-Like Carcinoma:

Name: Lymphoepithelioma-Like Carcinoma 12 14
Lymphoepithelial Carcinoma 12 69
Nasopharyngeal Type Undifferentiated Carcinoma 12

Classifications:



External Ids:

Disease Ontology 12 DOID:5660
NCIt 47 C4107
SNOMED-CT 64 7300000
UMLS 69 C0334254

Summaries for Lymphoepithelioma-Like Carcinoma

Disease Ontology : 12 A carcinoma that is a malignant epithelial neoplasm densely infiltrated by lymphoid cells.

MalaCards based summary : Lymphoepithelioma-Like Carcinoma, also known as lymphoepithelial carcinoma, is related to gastritis and cervical lymphoepithelioma-like carcinoma. An important gene associated with Lymphoepithelioma-Like Carcinoma is KRT20 (Keratin 20), and among its related pathways/superpathways are Keratinization and Cytoskeletal Signaling. The drugs Paclitaxel and Cisplatin have been mentioned in the context of this disorder. Affiliated tissues include skin, lung and breast, and related phenotype is Decreased shRNA abundance (Z-score < -2).

Wikipedia : 71 Lymphoepithelioma-like carcinoma (LELC) is a medical term referring to a histological variant of... more...

Related Diseases for Lymphoepithelioma-Like Carcinoma

Diseases related to Lymphoepithelioma-Like Carcinoma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 156)
id Related Disease Score Top Affiliating Genes
1 gastritis 30.1 CDH1 KRT20
2 cervical lymphoepithelioma-like carcinoma 12.2
3 infiltrating bladder lymphoepithelioma-like carcinoma 12.2
4 lymphoepithelioma-like thymic carcinoma 11.3
5 mucinous cystadenocarcinoma 10.3 KRT18 MUC1
6 trophoblastic neoplasm 10.3 KRT20 MUC1
7 neurofibrosarcoma 10.3 KRT20 MUC1
8 pelvic inflammatory disease 10.3 KRT20 MUC1
9 anemia of prematurity 10.3 KRT20 MUC1
10 penis paget's disease 10.3 CD274 MUC1
11 occipital encephalocele 10.3 KRT18 KRT8
12 woolly hair, autosomal dominant 10.3 KRT18 KRT8
13 proteus-like syndrome 10.3 KRT18 KRT8
14 cauda equina intradural extramedullary astrocytoma 10.3 KRT18 MUC1
15 mesenchymoma 10.3 KRT20 MUC1
16 bartholin's gland adenoid cystic carcinoma 10.3 KRT18 KRT8
17 papillary adenofibroma 10.3 KRT20 MUC1
18 mediastinum liposarcoma 10.3 KRT8 MUC1
19 sagittal sinus thrombosis 10.3 KRT20 MUC1
20 subependymal glioma 10.3 KRT20 MUC1
21 tabes dorsalis 10.3 KRT20 MUC1
22 large cell neuroendocrine carcinoma 10.2 KRT20 KRT8
23 tumor of exocrine pancreas 10.2 KRT20 MUC1
24 lymphoma 10.2
25 ovarian embryonal carcinoma 10.2 KRT18 KRT8
26 pediculus humanus corporis infestation 10.2 KRT18 KRT8
27 tanycytic ependymoma 10.2 CDH1 MUC1
28 ovarian squamous cell carcinoma 10.2 CDH1 KRT20
29 malignant epithelial mesothelioma 10.2 CDH1 MUC1
30 perivascular epithelioid cell tumor 10.2 KRT20 UPK3A
31 cervix endometriosis 10.2 KRT20 UPK3A
32 infiltrative basal cell carcinoma 10.2 CDH1 KRT20
33 granulocytopenia 10.2 CDH1 KRT20
34 familial renal oncocytoma 10.2 CDH1 KRT20
35 neuroendocrine tumor 10.2 KRT20 UPK3A
36 vulva squamous cell carcinoma 10.2 KRT20 UPK3A
37 klatskin's tumor 10.2 KRT20 UPK3A
38 substance abuse 10.2 CDH1 MUC1
39 myotonia congenita 10.2 KRT20 UPK3A
40 prolactin producing pituitary tumor 10.2 KRT5 MUC1
41 uterine corpus endometrial stromal sarcoma 10.2 KRT20 UPK3A
42 laryngeal mucoepidermoid carcinoma 10.2 KRT5 MUC1
43 small intestine leiomyoma 10.2 KRT20 KRT5
44 multidrug-resistant tuberculosis 10.2 KRT18 KRT5
45 differentiating neuroblastoma 10.2 CDH1 MUC1
46 intestinal benign neoplasm 10.2 KRT20 KRT8 MUC1
47 papilloma 10.2
48 sarcomatoid mesothelioma 10.2 KRT18 KRT8 MUC1
49 breast papillary carcinoma 10.2 CDH1 KRT18
50 prostate lymphoma 10.2 KRT5 KRT8

Graphical network of the top 20 diseases related to Lymphoepithelioma-Like Carcinoma:



Diseases related to Lymphoepithelioma-Like Carcinoma

Symptoms & Phenotypes for Lymphoepithelioma-Like Carcinoma

GenomeRNAi Phenotypes related to Lymphoepithelioma-Like Carcinoma according to GeneCards Suite gene sharing:

26
id Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Decreased shRNA abundance (Z-score < -2) GR00366-A-153 9.47 KRT5
2 Decreased shRNA abundance (Z-score < -2) GR00366-A-154 9.47 KRT18
3 Decreased shRNA abundance (Z-score < -2) GR00366-A-17 9.47 KRT18 KRT5
4 Decreased shRNA abundance (Z-score < -2) GR00366-A-180 9.47 KRT5 KRT8
5 Decreased shRNA abundance (Z-score < -2) GR00366-A-200 9.47 KRT5
6 Decreased shRNA abundance (Z-score < -2) GR00366-A-33 9.47 KRT18
7 Decreased shRNA abundance (Z-score < -2) GR00366-A-40 9.47 KRT8
8 Decreased shRNA abundance (Z-score < -2) GR00366-A-71 9.47 KRT18 KRT5 KRT8
9 Decreased shRNA abundance (Z-score < -2) GR00366-A-84 9.47 KRT18
10 Decreased shRNA abundance (Z-score < -2) GR00366-A-91 9.47 KRT5

Drugs & Therapeutics for Lymphoepithelioma-Like Carcinoma

Drugs for Lymphoepithelioma-Like Carcinoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 175)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Paclitaxel Approved, Vet_approved Phase 2, Phase 3, Phase 1 33069-62-4 36314
2
Cisplatin Approved Phase 3,Phase 2,Phase 1 15663-27-1 84093 441203 2767
3
Carboplatin Approved Phase 2, Phase 3,Phase 1 41575-94-4 10339178 498142 38904
4
Gemcitabine Approved Phase 2, Phase 3,Phase 1 95058-81-4 60750
5
Fluorouracil Approved Phase 3,Phase 2,Phase 1 51-21-8 3385
6
Fluconazole Approved Phase 2, Phase 3 86386-73-4 3365
7
Miconazole Approved, Investigational, Vet_approved Phase 2, Phase 3,Phase 1 22916-47-8 4189
8
Cevimeline Approved Phase 3 107233-08-9 83898 25137844
9
Amifostine Approved, Investigational Phase 3,Phase 2 20537-88-6 2141
10
Lenograstim Approved Phase 3,Phase 2,Phase 1 135968-09-1
11
Megestrol acetate Approved, Vet_approved Phase 3 595-33-5 11683
12
Fentanyl Approved, Illicit, Investigational, Vet_approved Phase 3 437-38-7 3345
13
Histamine Approved, Investigational Phase 3 75614-87-8, 51-45-6 774
14
Doxepin Approved Phase 3 1668-19-5 667477 667468
15
Docetaxel Approved May 1996, Investigational Phase 3,Phase 2,Phase 1 114977-28-5 148124 9877265
16 Analgesics Phase 3,Phase 2
17 Neurotransmitter Agents Phase 3,Phase 2
18 Albumin-Bound Paclitaxel Phase 2, Phase 3, Phase 1
19 Cytochrome P-450 Enzyme Inhibitors Phase 2, Phase 3
20 Nucleic Acid Synthesis Inhibitors Phase 3,Phase 2,Phase 1
21 Peripheral Nervous System Agents Phase 3,Phase 2
22 Anti-Bacterial Agents Phase 3,Phase 2,Phase 1
23 Anti-Infective Agents Phase 2, Phase 3, Phase 1
24 Immunosuppressive Agents Phase 3,Phase 2,Phase 1
25 Liver Extracts Phase 3,Phase 2,Phase 1
26 Antimetabolites Phase 3,Phase 2,Phase 1
27 Antibiotics, Antitubercular Phase 3,Phase 2,Phase 1
28 Antimetabolites, Antineoplastic Phase 3,Phase 2,Phase 1
29 Antimitotic Agents Phase 2, Phase 3, Phase 1
30 Autonomic Agents Phase 3,Phase 2
31 Antineoplastic Agents, Phytogenic Phase 2, Phase 3, Phase 1
32 Antiviral Agents Phase 2, Phase 3,Phase 1
33
Cobalt Phase 3 7440-48-4 104729
34 Porfiromycin Phase 3
35
Megestrol Phase 3 3562-63-8 19090 3080587
36 pancreatic polypeptide Phase 3
37 Alkylating Agents Phase 3,Phase 2
38 Mitomycins Phase 3
39 Cholinergic Agents Phase 3
40 Adjuvants, Anesthesia Phase 3
41 Adjuvants, Immunologic Phase 3,Phase 2,Phase 1
42 Narcotics Phase 3
43 Steroid Synthesis Inhibitors Phase 2, Phase 3
44 Contraceptive Agents Phase 3
45 Contraceptives, Oral Phase 3
46 Cytochrome P-450 CYP2C9 Inhibitors Phase 2, Phase 3
47 Analgesics, Opioid Phase 3
48 Hormone Antagonists Phase 2, Phase 3
49 Anesthetics Phase 3
50 Hormones Phase 2, Phase 3,Phase 1

Interventional clinical trials:

(show top 50) (show all 95)
id Name Status NCT ID Phase
1 Radiation Therapy Alone Compared to Radiation Therapy Plus Chemotherapy in Treating Patients With Previously Untreated Cancer of the Nasopharynx Unknown status NCT00003637 Phase 3
2 Radiation Therapy, Amifostine, and Chemotherapy in Treating Young Patients With Newly Diagnosed Nasopharyngeal Cancer Completed NCT00274937 Phase 3
3 Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain Completed NCT00538850 Phase 3
4 Acupuncture or Standard Therapy in Treating Pain and Dysfunction in Patients Who Have Undergone Neck Surgery for Head and Neck Cancer Completed NCT00090337 Phase 3
5 Cevimeline in Treating Patients With Dry Mouth Caused by Radiation Therapy for Head and Neck Cancer Completed NCT00017511 Phase 3
6 Fluconazole in Preventing Mucositis in Patients Undergoing Radiation Therapy for Head and Neck Cancer Completed NCT00002533 Phase 2, Phase 3
7 Radiation Therapy and Chemotherapy in Treating Patients With Head and Neck Cancer Completed NCT00002507 Phase 3
8 Megestrol to Limit Weight Loss and Improve Quality of Life in Treating Patients With Head and Neck Cancer Completed NCT00006799 Phase 3
9 Study of Nutrition Regimens in Treating Patients With Cancer of the Upper Aerodigestive Tract Completed NCT00765440 Phase 3
10 Fractionated Radiation Therapy in Treating Advanced Squamous Cell Carcinoma of the Head and Neck Completed NCT00771641 Phase 3
11 Cisplatin and RT With or Without Gemcitabine, Carboplatin, and Paclitaxel in Treating Patients With Locally Advanced NPC Active, not recruiting NCT00997906 Phase 2, Phase 3
12 Doxepin Hydrochloride in Treating Oral Mucositis Pain in Patients With Head and Neck Cancer Undergoing Radiation Therapy With or Without Chemotherapy Active, not recruiting NCT01156142 Phase 3
13 Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer That Cannot Be Removed By Surgery Terminated NCT00113399 Phase 3
14 Docetaxel and St. John's Wort in Treating Patients With Solid Tumors That Cannot Be Removed By Surgery Withdrawn NCT00041171 Phase 3
15 Gemcitabine and Carboplatin Followed By Laboratory-Treated T Lymphocytes in Treating Patients With Metastatic or Locally Recurrent Epstein-Barr Virus-Positive Nasopharyngeal Cancer Unknown status NCT00690872 Phase 2
16 Vaccine Therapy and Celecoxib in Treating Patients With Metastatic Nasopharyngeal Cancer Unknown status NCT00589186 Phase 2
17 Fluorouracil, Cisplatin, and Radiation Therapy in Treating Patients With Stage II, Stage III, or Stage IV Nasopharyngeal Cancer Unknown status NCT00093665 Phase 2
18 Antineoplaston Therapy in Treating Patients With Advanced Head and Neck Cancer Unknown status NCT00003489 Phase 2
19 Docetaxel and S-1 Followed By Radiation Therapy and Low-Dose Cisplatin in Treating Patients With Stage III or Stage IV Head and Neck Cancer Unknown status NCT00625937 Phase 2
20 Cisplatin-Epinephrine Injectable Gel Plus Paclitaxel and Carboplatin in Treating Patients With Recurrent Head and Neck Cancer Unknown status NCT00022217 Phase 2
21 Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Previously Untreated Advanced Cancer of the Mouth, Pharynx, or Larynx Unknown status NCT00004094 Phase 2
22 External-Beam Radiation Therapy With or Without Indinavir and Ritonavir in Treating Patients With Brain Metastases Unknown status NCT00637637 Phase 2
23 Cetuximab (ERBITUX®) Added to Two Concurrent Chemoradiotherapy Platforms in Locally Advanced Head and Neck Cancer Unknown status NCT00468169 Phase 2
24 Phenylbutyrate and Valganciclovir in Treating Patients With Relapsed or Refractory Epstein-Barr Virus-Positive Cancer Unknown status NCT00387530 Phase 2
25 Adjuvant Cetuximab and Chemoradiotherapy Using Either Cisplatin or Docetaxel in Treating Patients With Resected Stage III or Stage IV Squamous Cell Carcinoma or Lymphoepithelioma of the Head and Neck Completed NCT00084318 Phase 2
26 Imatinib Mesylate in Treating Patients With Salivary Gland Cancer Completed NCT00045669 Phase 2
27 Pazopanib Hydrochloride in Treating Patients With Stage IV or Recurrent Nasopharyngeal Cancer Completed NCT00454142 Phase 2
28 Bevacizumab, Cisplatin, Radiation Therapy, and Fluorouracil in Treating Patients With Stage IIB, Stage III, Stage IVA, or Stage IVB Nasopharyngeal Cancer Completed NCT00408694 Phase 2
29 Bevacizumab in Reducing CNS Side Effects in Patients Who Have Undergone Radiation Therapy to the Brain for Primary Brain Tumor, Meningioma, or Head and Neck Cancer Completed NCT00492089 Phase 2
30 Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung Cancer Completed NCT00101348 Phase 1, Phase 2
31 High-Dose Radiation Therapy Plus Chemotherapy in Treating Patients With Advanced Nose or Throat Cancer Completed NCT00052429 Phase 1, Phase 2
32 High-dose ICE With Amifostine Completed NCT00003657 Phase 2
33 Docetaxel in Treating Patients With Solid Tumors Completed NCT00003565 Phase 2
34 Chemotherapy in Treating Patients With Solid Tumors Completed NCT00003103 Phase 1, Phase 2
35 Oxaliplatin and Capecitabine in Treating Patients With Relapsed or Metastatic Head and Neck Cancer Completed NCT00448552 Phase 2
36 Epirubicin, Carboplatin, and Capecitabine in Treating Patients With Unresectable Locally Advanced, Metastatic, or Recurrent Solid Tumor Completed NCT00021047 Phase 1, Phase 2
37 Vaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid Tumors Completed NCT00019331 Phase 2
38 Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced Mouth Cancer Completed NCT00004901 Phase 1, Phase 2
39 Gemcitabine and Doxorubicin in Treating Patients With Recurrent or Progressive Head and Neck Cancer Completed NCT00509665 Phase 2
40 Paclitaxel and Cisplatin Plus Radiation Therapy Followed by Filgrastim in Treating Patients With Recurrent Head and Neck Cancer or Lung Cancer Completed NCT00021333 Phase 2
41 Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Rare Cancer Completed NCT00002515 Phase 2
42 Phase 2 Sequential and Concurrent Chemoradiation for Advanced Nasopharyngeal Carcinoma (NPC) Recruiting NCT00896181 Phase 2
43 18F FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy Recruiting NCT01806675 Phase 1, Phase 2
44 MRI Mapping in Planning Radiation Therapy to the Base of Skull and Brain in Patients With Nonmetastatic Head and Neck Cancer Unknown status NCT00984074 Phase 1
45 Functional MRI in Finding Hypoxia in Patients Undergoing Chemotherapy and Radiation Therapy for Stage III or Stage IV Head and Neck Cancer Unknown status NCT00896350 Phase 1
46 Bevacizumab, Fluorouracil, and Hydroxyurea Plus Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer Completed NCT00023959 Phase 1
47 Alvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors Completed NCT00089362 Phase 1
48 Cetuximab and Everolimus in Treating Patients With Metastatic or Recurrent Colon Cancer or Head and Neck Cancer Completed NCT01637194 Phase 1
49 Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer Completed NCT00397384 Phase 1
50 7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007) Completed NCT00031681 Phase 1

Search NIH Clinical Center for Lymphoepithelioma-Like Carcinoma

Genetic Tests for Lymphoepithelioma-Like Carcinoma

Anatomical Context for Lymphoepithelioma-Like Carcinoma

MalaCards organs/tissues related to Lymphoepithelioma-Like Carcinoma:

39
Skin, Lung, Breast, Cervix, Salivary Gland, Colon, Ovary

Publications for Lymphoepithelioma-Like Carcinoma

Articles related to Lymphoepithelioma-Like Carcinoma:

(show top 50) (show all 297)
id Title Authors Year
1
(18)F-FDG PET/CT of common hepatic duct lymphoepithelioma-like carcinoma. ( 27836588 )
2017
2
Mixed lymphoepithelioma-like carcinoma and adenocarcinoma of the gallbladder. ( 27621754 )
2016
3
Cytological features of lymphoepithelioma-like carcinoma of the breast. ( 27478161 )
2016
4
Pulmonary lymphoepithelioma-like carcinoma with echinoderm microtubule-associated protein-like 4-anaplastic lymphoma kinase (EML4-ALK) fusion gene. ( 28031835 )
2016
5
Pure Lymphoepithelioma-Like Carcinoma Originating from the Urinary Bladder. ( 27099604 )
2016
6
Dermoscopic Features of Cutaneous Lymphoepithelioma-like Carcinoma. ( 27930377 )
2016
7
Clinicopathological features and prognosis of primary pulmonary lymphoepithelioma-like carcinoma. ( 27747015 )
2016
8
A case of lymphoepithelioma-like carcinoma of the uterine cervix in a patient with a history of high-grade squamous intraepithelial lesion. ( 27343338 )
2016
9
Surgical treatment for primary pulmonary lymphoepithelioma-like carcinoma. ( 26993476 )
2016
10
An Unusual Case of Lymphoepithelioma-Like Carcinoma of the External Auditory Canal. ( 27755455 )
2016
11
Primary Lymphoepithelioma-Like Carcinoma of the Prostate Gland: A Review of the Literature. ( 26881187 )
2016
12
Utility of 18F-FDG PET/CT in the assessment of lymphoepithelioma-like carcinoma. ( 26741291 )
2016
13
Lymphoepithelioma-like carcinoma of the breast - A case report and brief review of the literature. ( 27773103 )
2016
14
Lymphoepithelioma-like Carcinoma (LELC) of the Prostate. ( 26977409 )
2016
15
Lymphoepithelioma-like carcinoma of the bladder: A case report. ( 27377093 )
2016
16
Unusual presentation of pulmonary lymphoepithelioma-like carcinoma. ( 27516893 )
2016
17
Extensive Metastases on 18F-FDG PET/CT in Primary Lymphoepithelioma-Like Carcinoma of the Ovary. ( 27607167 )
2016
18
Lymphoepithelioma-like carcinoma of breast-evaluation for Epstein-Barr virus-encoded RNA, human papillomavirus, and markers of basal cell differentiation. ( 27806845 )
2016
19
Lymphoepithelioma-Like Carcinoma of the Skin-A Rare Tumor Treated by Slow Mohs Micrographic Surgery. ( 27846013 )
2016
20
(18)F-FDG PET/CT in gastric lymphoepithelioma-like carcinoma. ( 26746813 )
2016
21
Primary pulmonary lymphoepithelioma-like carcinoma initially diagnosed as squamous metaplasia: A case report and literature review. ( 25789039 )
2015
22
EBV-associated lymphoepithelioma-like carcinoma of the pancreas: Case report with targeted sequencing analysis. ( 25922198 )
2015
23
PD-L1 is remarkably over-expressed in EBV-associated pulmonary lymphoepithelioma-like carcinoma and related to poor disease-free survival. ( 26361045 )
2015
24
LYMPHOEPITHELIOMA-LIKE CARCINOMA OF THE URINARY BLADDER ASSOCIATED WITH SCHISTOSOMIASIS: A CASE REPORT AND REVIEW OF LITERATURE. ( 26485857 )
2015
25
Lymphoepithelioma-like carcinoma of the urinary bladder: A rare case report. ( 26692678 )
2015
26
Intrahepatic Cholangiocarcinoma With Lymphoepithelioma-like Carcinoma Components Not Associated With Epstein-Barr Virus: Report of a Case. ( 25875552 )
2015
27
Detection of rearrangement of anaplastic lymphoma kinase (ALK) and mutation of epidermal growth factor receptor (EGFR) in primary pulmonary lymphoepithelioma-like carcinoma. ( 26543602 )
2015
28
Pulmonary lymphoepithelioma-like carcinoma: a Surveillance, Epidemiology, and End Results database analysis. ( 26793355 )
2015
29
An Elevated Peripheral Blood Monocyte-to-Lymphocyte Ratio Predicts Poor Prognosis in Patients with Primary Pulmonary Lymphoepithelioma-Like Carcinoma. ( 25950432 )
2015
30
A rare case of non-Epstein-Barr virus-associated lymphoepithelioma-like carcinoma of the esophagus treatedA withA endoscopic submucosal dissection. ( 26297869 )
2015
31
Lymphoepithelioma-like carcinoma: A distinct type of gastric cancer. ( 25592274 )
2015
32
A Case of Lymphoepithelioma-like Carcinoma in the Uterine Cervix. ( 25918614 )
2015
33
Esophageal Lymphoepithelioma-Like Carcinoma with Unique Daisy-Like Appearance. ( 26668803 )
2015
34
External beam radiotherapy for focal lymphoepithelioma-like carcinoma in the urinary bladder: a case report and literature review. ( 25759655 )
2015
35
Spontaneous Regression of Pulmonary Lymphoepithelioma-Like Carcinoma. ( 26046875 )
2015
36
Computed tomography findings for a gastric lymphoepithelioma-like carcinoma: How often does it present as a submucosal mass? ( 26628066 )
2015
37
PD-L1 is highly expressed in lung lymphoepithelioma-like carcinoma: A potential rationale for immunotherapy. ( 25862146 )
2015
38
Positive expression of programmed death ligand-1 correlates with superior outcomes and might be a therapeutic target in primary pulmonary lymphoepithelioma-like carcinoma. ( 26109869 )
2015
39
Lymphoepithelioma-like Carcinoma of the Skin in the Cheek with a Malignant Metastatic Cervical Lymph Node. ( 26430652 )
2015
40
Successful Treatment with Carboplatin and Pemetrexed for Multiple Lymph Node Metastases of Lymphoepithelioma-like Carcinoma from an Unknown Primary Site. ( 26466705 )
2015
41
Lymphoepithelioma-like carcinoma of the skin in a Polish patient. ( 25821429 )
2015
42
Collision of lymphoepithelioma-like carcinoma and adenocarcinoma of the lung: a case report. ( 26476129 )
2015
43
Lymphoepithelioma-like carcinoma of the skin: an exceedingly rare primary skin tumor. ( 25814759 )
2015
44
18F-FDG PET/CT of Liver Lymphoepithelioma-like Carcinoma. ( 26018687 )
2015
45
Lymphoepithelioma-Like Carcinoma of the Urinary Bladder. ( 26089221 )
2015
46
Non-Epstein-Barr virus-associated double primary lymphoepithelioma-like carcinoma of the esophagus and stomach: a case report and literature review. ( 26309699 )
2015
47
Lymphoepithelioma-like Carcinoma of Endometrium; A Rare Case Report. ( 26405421 )
2015
48
Non-nasopharyngeal head and neck lymphoepithelioma-like carcinoma in the United States: A population-based study. ( 26316257 )
2015
49
The differences in clinicopathological features and prognosis among the subtypes of signet ring cell, mucinous, papillary, and lymphoepithelioma-like carcinoma in advanced gastric cancer. ( 25713922 )
2014
50
Paraneoplastic pemphigus associated with metastatic lymphoepithelioma-like carcinoma originating from the thyroid gland. ( 25112893 )
2014

Variations for Lymphoepithelioma-Like Carcinoma

Expression for Lymphoepithelioma-Like Carcinoma

Search GEO for disease gene expression data for Lymphoepithelioma-Like Carcinoma.

Pathways for Lymphoepithelioma-Like Carcinoma

Pathways related to Lymphoepithelioma-Like Carcinoma according to GeneCards Suite gene sharing:

id Super pathways Score Top Affiliating Genes
1
Show member pathways
11.91 KRT18 KRT20 KRT5 KRT8
2 11.58 CDH1 KRT18 KRT20 KRT5 KRT8 MUC1
3
Show member pathways
11.54 CD274 PDCD1 PTPRC
4
Show member pathways
11.47 KRT18 KRT5 KRT8
5 11.42 CD274 CDH1 PDCD1 PTPRC

GO Terms for Lymphoepithelioma-Like Carcinoma

Cellular components related to Lymphoepithelioma-Like Carcinoma according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 extracellular exosome GO:0070062 9.56 CD274 CDH1 KRT18 KRT5 KRT8 MUC1
2 external side of plasma membrane GO:0009897 9.43 CD274 PDCD1 PTPRC
3 keratin filament GO:0045095 9.33 KRT18 KRT5 KRT8
4 intermediate filament GO:0005882 8.92 KRT18 KRT20 KRT5 KRT8

Biological processes related to Lymphoepithelioma-Like Carcinoma according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 extrinsic apoptotic signaling pathway GO:0097191 9.26 KRT18 KRT8
2 keratinization GO:0031424 9.26 KRT18 KRT20 KRT5 KRT8
3 hepatocyte apoptotic process GO:0097284 9.16 KRT18 KRT8
4 cornification GO:0070268 8.92 KRT18 KRT20 KRT5 KRT8

Molecular functions related to Lymphoepithelioma-Like Carcinoma according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 protein binding GO:0005515 9.65 CD274 CDH1 KRT18 KRT20 KRT5 KRT8
2 scaffold protein binding GO:0097110 8.8 KRT18 KRT5 KRT8

Sources for Lymphoepithelioma-Like Carcinoma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....